Investments
David Tepper gets US approval to take activist stance on Allergan
Allergan could face activist pressure from David Tepper’s Appaloosa Management after the Federal Trade Commission cleared the way for him to build on his stake in the drug-maker. Shares rose 3.7 percent on Thursday but […]